News about Global Pharma

Biocon Ltd - Update on US FDA Inspection at Biocon Biologics' Manufacturing Facility in Johor, Malaysia

Biocon Ltd - Update on US FDA Inspection at Biocon Biologics' Manufacturing Facility in Johor, Malaysia

The FDA has determined the inspection classification as 'OAI' (Official Action Indicated). The OAI status may cause delay and/or withholding of pending product approvals or supplements from the facility.

Global Pharma | 23/10/2023 | By Manvi 754

Aldena Therapeutics Selects PCI Pharma Services to Manufacture and Distribute Innovative Investigational Treatment for Dermatological Diseases

Aldena Therapeutics Selects PCI Pharma Services to Manufacture and Distribute Innovative Investigational Treatment for Dermatological Diseases

Dermatological diseases affect more than 900 million people worldwide. Significant advancements in the treatment of various skin conditions and disorders have been made.

Global Pharma | 23/10/2023 | By Manvi 513

C2 PHARMA Expands API Portfolio with Global Regulatory Access Ahead of CPhI Barcelona

C2 PHARMA Expands API Portfolio with Global Regulatory Access Ahead of CPhI Barcelona

C2 PHARMA is expanding its global access to its portfolio of active pharmaceutical ingredients (APIs) with new regulatory submissions and approvals.

Global Pharma | 18/10/2023 | By Manvi 1005

Linde Starts Up New Air Separation Unit in Hyderabad

Linde Starts Up New Air Separation Unit in Hyderabad

This plant will be producing in total 250 tonnes per day of gases including liquid medical oxygen, nitrogen and argon, catering to the requirements of healthcare, pharma and other industrial sectors of the region.

Global Pharma | 18/10/2023 | By Manvi 482

Zydus Appoints Punit Patel as President and CEO to Lead its Business Operations in North America

Zydus Appoints Punit Patel as President and CEO to Lead its Business Operations in North America

He will be responsible for the business operations of all Zydus entities in North America which include generics, injectables and specialty business, rare and orphan disease portfolio and also future forays into novel therapeutics. He will be based out of the group's office in Pennington, New Jersey, US.

Global Pharma | 18/10/2023 | By Manvi 870

Bajaj Healthcare Completes Construction of Alkaloid Extraction Plant at Gujarat Unit

Bajaj Healthcare Completes Construction of Alkaloid Extraction Plant at Gujarat Unit

The company has Constructed Alkaloid Extraction plant at its Vadodara Unit situated at Gujarat. Plant has a capacity for extraction of 2500 Mt of poppy Straw & 300 Mt Poppy Gum per year.

Global Pharma | 16/10/2023 | By Manvi 1022

Granules India Signs MoU with NIPER to Establish CCE-ISPD

Granules India Signs MoU with NIPER to Establish CCE-ISPD

The centre will focus on crucial areas such as exploring plant-based excipients, advancements in polymer-free pharmaceutical formulations, innovative methods in producing directly compressible crystals, promotion of solvent-free pharmaceutical processes, and the development of resource-efficient and energy-efficient pharmaceutical products.

Global Pharma | 16/10/2023 | By Manvi 670

Bormioli Pharma Announces Winner of Call4Ideas Launched in Collaboration with Desall

Bormioli Pharma Announces Winner of Call4Ideas Launched in Collaboration with Desall

The competition, which aimed to innovate traditional CRC locking systems through the introduction of biometric technologies, attracted 37 design proposals.

Global Pharma | 16/10/2023 | By Manvi 621

SGD Pharma Expands Sterinity Glass Vials for Parenteral Pharmaceutical Applications

SGD Pharma Expands Sterinity Glass Vials for Parenteral Pharmaceutical Applications

The launch of additional sizes 10H*ml and 20H ml in tray is advantageous to customers who will benefit from increased flexibility as a result of the extended portfolio.

Global Pharma | 16/10/2023 | By Manvi 874

BioMap Collaborates with Sanofi to Co-Develop AI Modules for Biotherapeutic Drug Discovery

BioMap Collaborates with Sanofi to Co-Develop AI Modules for Biotherapeutic Drug Discovery

BioMap is eligible to receive payments of more than $1 billion based on achievement of preclinical development, clinical development, regulatory, and commercial milestones.

Global Pharma | 11/10/2023 | By Manvi 1134

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members